Fly News Breaks for April 14, 2015
JNJ, SYK, ZMH
Apr 14, 2015 | 14:48 EDT
Wells Fargo says that Johnson & Johnson's (JNJ) hip and knee growth slowed in Q1 versus Q4, but U.S. knee growth accelerated to 2% in Q1 versus 1% growth in Q4, while U.S. hip growth was flat sequentially. The firm says it was encouraged by the similar sequential growth in the U.S. despite soft growth overseas. The firm notes that Stryker reports its results on April 21, while Zimmer reports on April 30.
News For ZMH;SYK;JNJ From the Last 2 Days
JNJ
Mar 18, 2024 | 07:07 EDT
Clearside Biomedical (CLSD) announced that Victor Chong, M.D., MBA was appointed Chief Medical Officer on March 14, 2024. Dr. Chong is a board-certified retinal specialist with more than 25 years of experience as a retinal physician and navigating all phases of ophthalmic drug development. Dr. Chong served most recently as VP, Global Head of Retina DAS at Johnson & Johnson (JNJ) Innovative Medicine.